Catalyst Wire Dossier Catalyst Wire Dossier

Intranasal nanoemulsion adjuvanted recombinant pandemic influenza vaccine

· BlueWillow Biologics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Intranasal nanoemulsion adjuvanted recombinant pandemic influenza vaccine, covering 2024-08-22 to 2024-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults [Phase 1]

See pricing